AAV-mediated gene transfer of human pigment epithelium-derived factor inhibits Lewis lung carcinoma growth in mice

Oncology Reports

Volumn 27, Issue 4, 2012, Pages 1142-1148

  He, Sha Sha ^a   Shi, Hua Shan ^a   Yin, Tao ^a   Li, Yong Xia ^a   Luo, Shun Tao ^a   Wu, Qin Jie ^a   Lu, Lian ^a   Wei, Yu Quan ^a   Yang, Li ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

AAV PEDF; Angiogenesis; Apoptosis; LLC; Tumour

Indexed keywords

PARVOVIRUS VECTOR; PIGMENT EPITHELIUM DERIVED FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER GENE THERAPY; CANCER GROWTH; COLORIMETRY; DRUG EFFICACY; HUMAN; HUMAN CELL; IMMUNOGENICITY; KIDNEY FUNCTION; LEWIS CARCINOMA; LIVER FUNCTION; MALE; MICROVASCULATURE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR VOLUME; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CAPILLARIES; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; DEPENDOVIRUS; EYE PROTEINS; GENE THERAPY; GENETIC VECTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; SERPINS; TIME FACTORS; TRANSFECTION; TUMOR BURDEN;

EID: 84863012319     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1621     Document Type: Article

References (39)

1. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000. (Pubitemid 30046295)
2. Folkman J and Ingber D: Inhibition of angiogenesis. Semin Cancer Biol 3: 89-96, 1992.
3. Bicknell R and Harris AL: Anticancer strategies involving the vasculature: vascular targeting and the inhibition of angiogenesis. Semin Cancer Biol 3: 399-407, 1992.
4. Augustin HG: Translating angiogenesis research into the clinic: the challenges ahead. Br J Radiol 76: 3-10, 2003.
5. Shimizu K and Oku N: Cancer anti-angiogenic therapy. Biol Pharm Bull 27: 599-605, 2004. (Pubitemid 41694655)
6. Purow B and Fine HA: Progress report on the potential of angiogenesis inhibitors for neuro-oncology. Cancer Invest 22: 577-587, 2004. (Pubitemid 39506879)
7. Conway EM, Collen D and Carmeliet P: Molecular mechanisms of blood vessel growth. Cardiovasc Res 49: 507-521, 2001. (Pubitemid 32146414)
8. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specifific growth factors and blood vessel formation. Nature 407: 242-248, 2000.
9. Tombran-Tink J, Chader GG and Johnson LV: PEDF: A pigment epithelium derived factor with potent neuronal differentiative activity. Exp Eye Res 53: 11-14, 1991.
10. Becerra SP, Sagasti A, Spinella P, et al: Pigment epithelium-derived factor behaves like a non-inhibitory serpin. Nerothrophic activity does not require the serpin reactive loop. J Biol Chem 270: 25992-25999, 1995.
11. Filleur S, Nelius T, de Riese W and Kennedy RC: Characterization of PEDF: a multi-functional serpin family protein. J Cell Biochem 106: 769-775, 2009.
12. Tombran-Tink J and Johnson LV: Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 30: 1700-1707, 1989. (Pubitemid 19214990)
13. Bouck N: PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med 8: 330-334, 2002.
14. Dawson DW, Volpert OV, Gillis P, et al: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285: 245-248, 1999. (Pubitemid 29329995)
15. Houenou LJ, D'Costa AP, Li L, et al: Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J Comp Neurol 412: 506-514, 1999. (Pubitemid 29398706)
16. Abe R, Shimizu T, Yamagishi S, et al: Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 164: 1225-1232, 2004. (Pubitemid 38387789)
17. Garcia M, Fernandez Garcia NI, Rivas V, et al: Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumour activities of pigment epithelium-derived factor. Cancer Res 64: 5632-5642, 2004. (Pubitemid 39095559)
18. Yang LP, Cheng P, Peng XC, et al: Anti-tumour effect of adenovirus-mediated gene transfer of pigment epithelium-derived factor on mouse B16-F10 melanoma. J Exp Clin Cancer Res 28: 75, 2009.
19. Doll JA, Stellmach VM, Bouck NP, et al: Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 9: 774-780, 2003. (Pubitemid 36749229)
20. Filleur S, Volz K, Nelius T, et al: Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res 65: 5144-5152, 2005. (Pubitemid 40827323)
21. Guan M, Jiang H, Xu C, Xu R, Chen Z and Lu Y: Adenovirus-mediated PEDF expression inhibits prostate cancer cell growth and results in augmented expression of PAI-2. Cancer Biol Ther 6: 419-425, 2007. (Pubitemid 47328311)
22. Kojiro M, Hiroki I, Daisuke N, Keisuke H, Kazuhiko N and Katsumi E: Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology 40: 252-259, 2004.
23. Uehara H, Miyamoto M, Kato K, et al: Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res 64: 3533-3537, 2004. (Pubitemid 38657928)
24. Zhang L, Chen J, Ke Y, Mansel RE and Jiang WG: Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro. Oncol Rep 14: 1615-1619, 2005.
25. Ek ET, Dass CR, Contreras KG and Choong PF: PEDF-derived synthetic peptides exhibit antitumour activity in an orthotopic model of human osteosarcoma. J Orthop Res 25: 1671-1680, 2007. (Pubitemid 350293816)
26. Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T and Imaizumi T: Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 77: 3231-3241, 2005. (Pubitemid 41433323)
27. Zhang T, Guan M, Xu C, Chen Y and Lu Y: Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Life Sci 81: 1256-1263, 2007. (Pubitemid 47539504)
28. Volpert OV, Zaichuk T, Zhou W, et al: Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 8: 349-357, 2002. (Pubitemid 34407029)
29. Yamagishi S, Amano S, Inagaki Y, et al: Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties. Microvasc Res 65: 186-190, 2003. (Pubitemid 36438684)
30. Yamagishi S, Inagaki Y, Amano S, et al: Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem Biophys Res Commun 296: 877-882, 2002.
31. Cai J, Jiang WG, Grant MB and Boulton M: Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth fact receptor 1. J Biol Chem 281: 3604-3613, 2006. (Pubitemid 43845978)
32. Nathwani AC, Davidoff A, Hanawa H, et al: Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood 97: 1258-1265, 2001.
33. Zhang Z, Zeng G, Zhang L, Xu C and Guo Y: Extracellular domain of kinase domain region mediated by adeno-associated virus inhibits growth and angiogenesis of bladder cancer in Balb-c mice. Chin Med J (Engl) 115: 1209-1212, 2002. (Pubitemid 34947345)
34. Carter PJ and Samulski RJ: Adeno-associated viral vectors as gene delivery vehicles. Int J Mol Med 6: 17-27, 2000.
35. Wu X, Dong X, Wu Z, Cao H, Niu D, et al: A novel method for purification of recombinant adenoassociated virus vectors on a large scale. Chinese Sci Bull 46: 485-488, 2001.
36. Weidner N, Semple JP, Welch WR and Folkman J: Tumour angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
37. Wang X, Su C, Cao H, et al: A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts poten antitumour effificacy on common human solid cancers. Mol Cancer Ther 7: 1598-1603, 2008.
38. Hase R, Miyamoto M, Uehara H, et al: Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Clin Cancer Res 11: 8737-8744, 2005. (Pubitemid 43005924)
39. Mahtabifard A, Merritt RE, Yamada RE, Crystal RG and Korst RJ: In vivo gene transfer of pigment epithelium-derived factor inhibits tumour growth in syngeneic murine models of thoracic malignancies. J Thorac Cardiovasc Surg 126: 28-38, 2003. (Pubitemid 36909938)